| Literature DB >> 19851514 |
Hidekatsu Yanai1, Hiroshi Yoshida, Norio Tada.
Abstract
To find out clues to differentiate between polymyalgia rheumatica (PMR) and other diseases that mimic PMR. We studied Japanese patients with PMR (n = 7), pseudogout (n = 1), remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome (n = 1), and post-infectious polyarthritis (n = 1). The distribution of inflammation in patients was evaluated using a gallium-67 scintigraphy. We measured serum C-reactive protein (CRP), matrix metalloproteinase-3 (MMP-3), and vascular endothelial growth factor (VEGF) in patients before and after treatment. Further, we compared the clinical course of PMR with that of other diseases that mimic PMR. Patients with pseudogout, RS3PE syndrome, post-infectious polyarthritis manifested similar changes in scintigraphic findings and serum CRP, MMP-3, and VEGF levels to PMR before the treatment. A significant reduction in serum CRP levels at one week after use of nonsteroidal anti-inflammatory drugs (NSAIDs) is a good clue to differentiate pseudogout and post-infectious polyarthritis from PMR. Chondrocalcinosis in the radiographs of joints is also effective to differentiate pseudogout from PMR. A small reduction of CRP levels after NSAIDs use and promptly ameliorated CRP and symptoms by a low-dose steroid therapy, which was commonly observed in patients with PMR, were also found in a patient with RS3PE syndrome. Pitting edema of the back of hands and gallium uptake in metacarpophalangeal (MCP) joints were useful to differentiate RS3PE syndrome from PMR. In conclusion, pseudogout, RS3PE syndrome, post-infectious polyarthritis should be included in the spectrum of diseases mimicking PMR. A promptly decreased serum CRP level by NSAIDs is a good clue to differentiate pseudogout and post-infectious polyarthritis from PMR. Pitting edema of the back of hands and symmetric gallium uptake in MCP joints are characteristic for RS3PE syndrome.Entities:
Keywords: RS3PE syndrome; gallium-67 scintigraphy; polymyalgia rheumatica; post-infectious polyarthritis; pseudogout
Mesh:
Substances:
Year: 2009 PMID: 19851514 PMCID: PMC2762363 DOI: 10.2147/cia.s7489
Source DB: PubMed Journal: Clin Interv Aging ISSN: 1176-9092 Impact factor: 4.458
Figure 1Gallium-67 scintigraphic findings of patients with polymyalgia rheumatica (P), pseudogout A), remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome B), and post-infectious polyarthritis C). A–C corresponds to case A–C in Table 1, respectively. Arrows indicate a gallium uptake. Dotted arrows indicate a gallium uptake in metacarpophalangeal joints in a patient in RS3PE syndrome.
Age, serum CRP, MMP-3, VEGF levels before and after the treatment in patients with PMR, pseudogout, RS3PE syndrome, and post-infectious polyarthritis
| Case | Diagnosis | Age | CRP (mg/dl) | MMP-3 (ng/ml) | VEGF (pg/ml) | |
|---|---|---|---|---|---|---|
| PMR (n = 7) | 78.1 ± 8.2 | Before | 11.4 ± 4.8 | 189.0 ± 91.4 | 1,114.2 ± 297.4 | |
| After | 1.5 ± 1.0 | 286.9 ± 204.0 | 565.1 ± 182.3 | |||
| A | Pseudogout | 83 | Before | 24.3 | 252.0 | 1,190 |
| After | 1.2 | 117.0 | 894 | |||
| B | RS3PE syndrome | 65 | Before | 17.8 | 729.0 | 1,650 |
| After | 8.5 | 328.0 | 1070 | |||
| C | Post-infectious polyarthritis | 89 | Before | 12.1 | 238.0 | 805 |
| After | 1.3 | 70.1 | 450 |
Notes: Cases A–C corresponds to A–C in Figure 1, respectively. Values in PMR patients indicate mean ± SD.
P < 0.05 vs values before the treatment by Wilcoxon’s signed rank test. Normal range of CRP, MMP-3, and VEGF levels is <0.3 mg/dl, <115 ng/ml, and 17.3–59.7 pg/ml, respectively.
Abbreviations: CRP, C-reactive protein; MMP-3, matrix metalloproteinase-3; PMR, polymyalgia rheumatica; RS3PE, remitting seronegative symmetrical synovitis with pitting edema.
Changes in serum CRP levels after one week’s treatment using NSAIDs in patients with PMR, pseudogout, RS3PE syndrome, and post-infectious polyarthritis
| Case | Diagnosis | CRP (mg/dl) | %Changes of serum CRP levels | |
|---|---|---|---|---|
| PMR (n = 7) | Before | 10.4 ± 4.4 | −7.2% | |
| After one week | 9.1 ± 3.4 | |||
| A | Pseudogout | Before | 24.3 | −95.1% |
| After one week | 1.2 | |||
| B | RS3PE syndrome | Before | 20.8 | −22.1% |
| After one week | 16.2 | |||
| C | Post-infectious polyarthritis | Before | 12.1 | −89.3% |
| After one week | 1.3 |
Notes: Case A–C corresponds to A–C in Figure 1, respectively. Values in PMR patients indicate mean ± SD.
Indicates no significant differences vs values before treatment by Wilcoxon’s signed rank test.
Abbreviations: CRP, C-reactive protein; MMP-3, matrix metalloproteinase-3; PMR, polymya rheumatica; RS3PE, remitting seronegative symmetrical synovitis with pitting edema.
Figure 2The radiographs of the patient with pseudogout demonstrated chondrocalcinosis (arrows) on the wrist A), knee B), and hip C).
Clinical and biochemical characteristics for polymyalgia rheumatic
| Age ≥ 50 years |
| Elevated serum CRP, MMP-3, and VEGF levels |
| Symmetrical gallium-67 uptake in shoulders and/or pelvic girdle |
| A bad response to NSAIDs |
| A rapid response to steroid |
| No abnormalities in the radiographs of joints |
Abbreviations: CRP, C-reactive protein; MMP-3, matrix metalloproteinase-3; NSAIDs, nonsteroidal anti-inflammatory drugs.